Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Urogen Pharma Ltd. Ordinary Shares (NASDAQ: URGN)

$18.48 USD $0.07 (0.38%)
Last Price $18.48
Net Change $0.07 (0.38%)
Bid $0
Ask Price $0
Open Price $18.41
Previous Close Price $18.41
High Price $18.48
Low Price $17.88
Number of Trades 175
Volume 41,100
Fifty Two Week High $20.02 (2017-05-22)
Fifty Two Week Low $13.01 (2017-05-04)
Average Daily Volume 67,319
Share Outstanding 11,970 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $0
Last Quarter EPS $
Market Capitalization $0.22B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 11,970
Inst. Shareholder % 0%
Annual Net Income $0B
TTM Net Profit Margin $100
1-Year Return 32.19%
3-Year Return 32.19%
5-Year Return 32.19%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio
Beta
UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.

URGN News & Stock Updates